Shanghai's first mRNA COVID vaccine approved for clinical trials

Download

02:32

A Shanghai-developed COVID-19 mRNA vaccine has been approved for clinical trials by China's Center for Drug Evaluation. With volunteers for the first phase of trials now selected, manufacturers are gearing up for production.

Open in CGTN APP for better experience

Search Trends